|
| Issue Date | Title | Author(s) |
| 2017 | Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes | Teo, J.Q.-M; Candra, S.R; Lee, S.J.-Y; Chia, S.Y.-H; Leck, H; Tan, A.-L ; Neo, H.-P; Leow, K.W.-L; Cai, Y; Ee, R.P.-L ; Lim, T.-P ; Lee, W; Kwa, A.L.-H |
| 2018 | Correction: Candidemia in a major regional tertiary referral hospital - Epidemiology, practice patterns and outcomes (Antimicrobial Resistance and Infection Control (2017) 6 (27) DOI: 10.1186/s13756-017-0184-1) | Teo, J.Q.-M; Candra, S.R; Lee, S.J.-Y; Chia, S.Y.-H; Leck, H; Tan, A.-L; Neo, H.-P; Leow, K.W.-L; Cai, Y; Ee, P.L.R ; Lim, T.-P ; Lee, W; Kwa, A.L.-H |
| 2011 | Effective antibiotics in combination against extreme drug-resistant pseudomonas aeruginosa with decreased susceptibility to polymyxin B | Lim T.-P. ; Lee W.; Tan T.-Y.; Sasikala S.; Teo J.; Hsu L.-Y. ; Tan T.-T. ; Syahidah N.; Kwa A.L. |
| 2015 | Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: A molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations | Teo, J; Lim, T.-P ; Hsu, L.-Y ; Tan, T.-Y ; Sasikala, S; Hon, P.-Y ; Kwa, A.L ; Apisarnthanarak, A |
| 2016 | From Bench-Top to Bedside: A prospective In vitro Antibiotic Combination Testing (iACT) service to guide the selection of rationally optimized antimicrobial combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB) | Cai Y.; Chua N.G.; Lim T.-P. ; Teo J.Q.-M.; Lee W.; Kurup A. ; Koh T.-H. ; Tan T.-T. ; Kwa A.L. |
| 2011 | In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in Singapore | Lim T.-P. ; Tan T.-Y.; Lee W.; Sasikala S.; Tan T.-T. ; Hsu L.-Y. ; Kwa A.L. |
| 2-Apr-2020 | Interim treatment guidelines for COVID-19 (version 1.0), Singapore. | Vasoo, Shawn; TAN THUAN TONG ; SOPHIA ARCHULETA ; DAVID LYE CHIEN BOON ; Thong, Bernard; Howe, Hwee Siew; Kwa, Andrea ; Law, Hwa Lin; Hoo, Grace; Lin, Raymond ; Tan, Lisa; Foo, Yang Tong; ONG KIAT HOE ; Kurup, Asok ; Lee, Tau Hong; CATHERINE ONG WEI MIN ; Ang, Brenda |
| 6-Jul-2020 | Interim Treatment Guidelines for COVID-19 (Version 3.0, dated 6th July 2020) | Vasoo, Shawn; Tan, Thuan Tong ; Archuleta, Sophia ; Lye, David ; Thong, Bernard; Howe, Hwee Siew; Cross, Gail ; Kwa, Andrea ; Law, Hwa Lin; Hoo, Grace; Lin, Raymond; Tan, Lisa; Foo, Yang Tong; Ong, Kiat Hoe ; Kurup, Asok ; Lee, Tau Hong; Ong, Wei Min Catherine ; Ang, Brenda |
| 2015 | Prospective audit and feedback in antimicrobial stewardship: Is there value in early reviewing within 48 h of antibiotic prescription? | Liew, Y.X.; Lee, W.; Tay, D.; Tang, S.S.L.; Chua, N.G.S.; Zhou, Y.; Kwa, A.L.-H. ; Chlebicki, M.P. |
| 2012 | Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible enterobacteriaceae: A case-case-control study | Teo J.; Cai Y.; Tang S.; Lee W.; Tan T.Y.; Tan T.T. ; Kwa A.L.-H. |
| 2015 | Using an adenosine triphosphate bioluminescent assay to determine effective antibiotic combinations against carbapenem-resistant gram negative bacteria within 24 hours | Cai Y.; Leck H.; Lim T.P. ; Teo J.; Lee W.; Hsu L.Y. ; Koh T.H. ; Tan T.T. ; Tan T.-Y.; Kwa A.L.-H. |
